Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Alfa Chemistry Offers Fluorinated Building Blocks for Material, Medicinal, Agricultural, Organic Chemistry Research

    Oct 27, 2020, 00:04 AM by Abhinav Singh
    NY, NY - Oct 14, 2020 - The benefits of fluorochemistry to pharmaceutical applications are obvious and the past decades has seen increasing synthesis of fluorinated compounds in the preparation of new pharmaceuticals and agrochemicals
    Full story
  • AI & Medicine Announces Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling for Drug Discovery

    Oct 27, 2020, 00:01 AM by Abhinav Singh
    NY, NY, UNITED STATES - Oct 21, 2020 - AI & Medicine, one of the forerunners in the AI-assisted medicine area, announces it now provides PK/PD modeling service to help scientists and researchers more efficiently screen drugs and thus accelerating the process of new drug development
    Full story
  • Protheragen Offers License Opportunities for Drug Development Programs

    Oct 26, 2020, 23:55 PM by Abhinav Singh
    RONKONKOMA, NY - Oct 27, 2020 - Aiming to build a bridge between academics and industry, Protheragen, a company founded in Ronkonkoma, New York, 2009, announces to offer license opportunities for drug R&D companies
    Full story
  • Scientific Knowledge Discovery Platform Pioneer, Eagle Genomics, Closes $9M in Scale-Up Funding as Major Brands Home in on the Microbiome Megatrend

    Oct 26, 2020, 20:53 PM by Abhinav Singh
    CAMBRIDGE, UNITED KINGDOM - Oct 26, 2020 - Eagle Genomics, a pioneer in applying network science to biology – particularly linked to the microbiome – has closed $9 million in new scale-up funding
    Full story
  • Clinical Data Visualizations at BMS Merge Trial and Real-World Data

    Oct 26, 2020, 15:55 PM by User Not Found
    Bio-IT World | The probability of success is low in early drug discovery and gets progressively more expensive on the journey to marketing approval by the Food and Drug Administration (FDA). To “fail early and fail often” has thus become the mantra of medicine developers needing to direct resources to the candidates most likely to triumph, says Philip Ross, director of translational bioinformatics data science at Bristol-Myers Squibb (BMS). Only 9.6% of drugs that make it to phase I trials ever get FDA approved.
    Full story
  • Shimmer Solicits Clinical Research Community Input on Expanded Open Wearables Initiative (OWEAR) Vision

    Oct 26, 2020, 12:49 PM by Abhinav Singh
    CAMBRIDGE, MA - Oct 26, 2020 - Shimmer Research, a global leader in wearable technology for research applications, today announced that the Open Wearables Initiative (OWEAR) is evaluating a significant expansion of its vision and seeking industry input to build consensus
    Full story
  • NCH Healthcare System Partners with eVideon to Enhance Digital Patient Engagement and Education

    Oct 26, 2020, 10:55 AM by Abhinav Singh
    NEWTON, MI, UNITED STATES - Oct 26, 2020 - eVideon, a leader in interactive patient engagement and digital workflow solutions, today announced that NCH Healthcare System, one of the largest healthcare systems in Southwest Florida, will be implementing the company’s full suite of solutions in 576 patient rooms across its two hospitals
    Full story
  • AVIA Names Linda Finkel as CEO

    Oct 23, 2020, 11:12 AM by Abhinav Singh
    CHICAGO, IL, UNITED STATES - Oct 23, 2020 - AVIA, the nation’s leading digital transformation partner for healthcare organizations, announced that its board of directors has appointed AVIA President Linda Finkel to also serve as chief executive officer, effective November 1, 2020
    Full story
  • BOC Sciences Lanuched A New Biotinylation Platform

    Oct 23, 2020, 00:05 AM by Abhinav Singh
    SHIRLEY, NY, UNITED STATES - Oct 23, 2020 - Recently, BOC Sciences, a New York-based chemical and pharmaceutical supplier, announced to launch a new biotinylation technology platform for the scientific community
    Full story
  • Profacgen Updated Its Pull Down Assay Service for Protein Interaction Study

    Oct 22, 2020, 09:32 AM by Abhinav Singh
    SHIRLEY, NY, UNITED STATES - Oct 22, 2020 - Profacgen, with an organized team of scientists with extensive experience in the study of protein-protein interaction, recently updated its pull down assay service to help efficiently and specifically verify the predicted protein-protein interactions or identify novel interactions
    Full story
  • Elsevier Signs Collaboration to Develop Novel Prediction Tool to Reduce Drug Development Safety Risk

    Oct 22, 2020, 05:16 AM by Abhinav Singh
    LONDON, UNITED KINGDOM - Oct 22, 2020 - Elsevier, a global information analytics business specializing in science and health, today announced its collaboration with the pharmaceutical company Novartis to develop a safety margin risk assessment prediction tool, largely using PharmaPendium data
    Full story
  • Aurinia Pharmaceuticals selects MyMeds&Me’s Reportum QuickStart platform to streamline drug safety reporting

    Oct 21, 2020, 15:04 PM by Abhinav Singh
    LONDON, UK - Oct 21, 2020 - MyMeds&Me, a leading provider of drug safety software to transform the end-to-end pharmacovigilance process, have today announced that Aurinia Pharmaceuticals Inc
    Full story
  • Alfa Chemistry Testing Lab Builds an Exclusive Regulatory Resource Section on Its Website

    Oct 21, 2020, 00:14 AM by Abhinav Singh
    NY, NY - Oct 21, 2020 - For customers who are not familiar with industry regulations, Alfa Chemistry Testing Lab has recently built an exclusive section of regulatory resource section for them on its website for reference purposes
    Full story
  • MDI Biological Laboratory Awarded $3.14 Million for Kidney Research

    Oct 20, 2020, 13:30 PM by Abhinav Singh
    BAR HARBOR, ME, UNITED STATES - Oct 20, 2020 - The MDI Biological Laboratory has announced that it has received a grant of $3.14 million over five years from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an institute of the National Institutes of Health (NIH), for the development of artificial kidney tissue to replace human kidney tissue that is lost to disease or injury
    Full story
  • abeo Appoints Joe Ferro as Chief Technology and Innovation Officer

    Oct 20, 2020, 12:41 PM by Abhinav Singh
    DALLAS, TX, UNITED STATES - Oct 20, 2020 - abeo, a leader in physician-focused billing and practice management solutions, today announced its appointment of Joe Ferro to Chief Technology and Innovation Officer
    Full story
  • ATMPS advanced therapy blockchain platform has successful testing with NHS partners

    Oct 20, 2020, 12:31 PM by Abhinav Singh
    LONDON, UNITED KINGDOM - Oct 20, 2020 - : ATMPS Ltd – a spinout of FarmaTrust announces that its Hataali blockchain platform has been successfully tested with University Hospitals Birmingham NHS Foundation Trust’s system interface
    Full story
  • Optibrium Launches Cerella, a Novel Artificial Intelligence Platform for Active Learning in Drug Discovery

    Oct 20, 2020, 04:54 AM by Abhinav Singh
    CAMBRIDGE, UNITED KINGDOM - Oct 20, 2020 - Optibrium today announced the launch of Cerella, an Artificial Intelligence (AI) software platform for drug discovery that delivers active learning using advanced deep learning methods
    Full story
  • ‘High-Risk, High-Reward’ Approach To Finding Alzheimer’s Disease Treatments

    Oct 19, 2020, 18:45 PM by Michael Croft
    Bio-IT World The quest to find new medicines for Alzheimer’s disease (AD) may finally make some headway, thanks to a Target Enablement to Accelerate Therapy Development for Alzheimer’s Disease (TREAT-AD) project that is taking a “high-risk, high-reward” approach to diversifying the drug development pipeline, according to Lara Mangravite, president of Sage Bionetworks. The Seattle-based nonprofit is partnered with Emory University and the Structural Genomics Consortium (SGC) on the initiative.
    Full story
  • 908 Devices Announces New Additions to Its Executive Team

    Oct 16, 2020, 09:10 AM by Abhinav Singh
    BOSTON, MA, UNITED STATES - Oct 15, 2020 - 908 Devices, a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the appointment of two Vice Presidents to its executive team, including Maura Fitzpatrick as the Vice President of Product Management and Marketing; and Kevin McCallion as the Vice President of Production and New Product Introduction
    Full story
  • FOXP3 Protein Inhibited, Blocking Factor D Protein May Prevent Inflammatory Response, App Crowdsources Drug Candidates: COVID-19 Updates

    Oct 16, 2020, 01:20 AM by Michael Croft
    Bio-IT World I Cloud-based tool, IDseq, allows tracking of emerging pathogens, scientist who discovered SARS captures detailed look of immune system response to COVID-19, SARS-CoV-2 may become endemic, ORF3B identified as viral factor that impairs immune response, age is an independent factor to virus susceptibility, group of 80 researchers warns against herd immunity approach, high dose favipiravir had significant effect on preventing and treating virus in hamster model, REGN-COV2 antibody ‘cocktail’ offers protection in pre-clinical trial on macaques. Plus: SARS-CoV antibodies effectively neutralize SARS-CoV-2 infection in cultured cells, international open access database aims to reduce duplication of ongoing COVID-19 research and more.
    Full story
  • «
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189 (current)
  • 190
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy